|
FY2019
12 months to Mar 31, 2019
|
FY2018
12 months to Mar 31, 2018
|
FY2017
12 months to Mar 31, 2017
|
FY2016
12 months to Mar 31, 2016
|
FY2015
12 months to Mar 31, 2015
|
|
|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||
| Net income | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | |||||
| Depreciation | |||||
| Amortization of intangible assets | |||||
| Goodwill impairment | |||||
| Loss on sale of Southeast Asian durables business | |||||
| Loss on write-off of deferred financing fees | |||||
| Impairment loss on fixed assets related to facility closures | |||||
| Amortization of deferred financing costs | |||||
| Loss on benefit plans related to facility closures | |||||
| Gain on previously held equity interests | |||||
| Net (gain) loss on disposal of property, plant and equipment | |||||
| Net (gain) loss on derivative contracts | |||||
| Stock-based compensation expense | |||||
| Excess tax benefit from stock-based compensation | |||||
| Deferred income taxes, net | |||||
| Changes in assets and liabilities, net of acquisitions: | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable | |||||
| Accrued expenses and other liabilities | |||||
| Net cash provided by operating activities | |||||
| CASH FLOWS FROM INVESTING ACTIVITIES: | |||||
| Capital expenditures | |||||
| Investment in acquisitions, net of cash acquired | |||||
| Net proceeds from sale of Southeast Asian durables business | |||||
| Proceeds from sale of property, plant and equipment | |||||
| Net cash used in investing activities | |||||
| CASH FLOWS FROM FINANCING ACTIVITIES: | |||||
| Borrowings under revolving lines of credit | |||||
| Payments under revolving lines of credit | |||||
| Borrowings of long-term debt | |||||
| Repayments of long-term debt | |||||
| Payment of acquisition related deferred payments | |||||
| Buyout of non-controlling interest | |||||
| Proceeds from issuance of common stock | |||||
| Excess tax benefit from stock-based compensation | |||||
| Debt issuance costs | |||||
| Dividends paid | |||||
| Effect of foreign exchange rate changes on cash | |||||
| Net increase/(decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of year | |||||
| Cash and cash equivalents, end of year | |||||
| Net cash provided by (used in) financing activities | |||||
| Effect of foreign exchange rate changes on cash | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of year | |||||
| Cash and cash equivalents, end of year | |||||
Loading...